#Antimicrobial testing

[wikipediapictures]

Etest

“Etest being used to determine the susceptibility of Neisseria gonorrhoeae to benzylpenicillin.” - via Wikipedia

[thoratketan]

2025 Global Antimicrobial Susceptibility Testing Market: Forecast, Growth Drivers, And Challenges

The global Antimicrobial Susceptibility Testing (AST) Market was valued at USD 3.87 billion in 2023 and is projected to reach USD 6.04 billion by 2032, growing at a robust compound annual growth rate (CAGR) of 5.1% during the forecast period of 2024 to 2032. The market’s expansion is primarily driven by the increasing prevalence of antimicrobial resistance (AMR), the growing number of chronic and infectious diseases, as well as technological advancements in AST procedures.

Get Free Sample Report on Antimicrobial Susceptibility Testing Market 

Market Dynamics:

The rise in antimicrobial resistance (AMR) is one of the most pressing global health challenges of the 21st century. According to the World Health Organization (WHO), AMR leads to approximately 700,000 deaths globally every year and threatens to derail decades of medical progress. This growing crisis has underscored the need for rapid, accurate, and effective testing methods to guide treatment decisions and ensure the effective use of antimicrobial agents. As a result, the demand for antimicrobial susceptibility testing (AST) is expected to witness significant growth in the coming years.

AST is critical in identifying the most effective antimicrobial treatment options by determining the susceptibility of microorganisms to different antimicrobial agents. This not only ensures the correct treatment of patients but also helps curb the inappropriate use of antibiotics, which is a significant factor in the development of resistant bacteria. The rising focus on precision medicine, along with the continuous efforts to combat AMR, has resulted in a heightened demand for innovative and reliable AST solutions.

Key Market Drivers:

Increase in Antimicrobial Resistance (AMR): The continued rise in AMR is a major driver of the AST market. AMR occurs when microorganisms, including bacteria, fungi, viruses, and parasites, evolve to resist the drugs that were previously effective in treating them. This poses a serious threat to public health, particularly in hospital and clinical settings. The increased urgency surrounding AMR has led to governments and healthcare organizations focusing more resources on improving AST procedures and capabilities, which in turn accelerates market growth.

Technological Advancements in AST: Over the past few years, significant technological advancements have been made in the field of antimicrobial susceptibility testing. The development of high-throughput screening, molecular diagnostic techniques, automated platforms, and next-generation sequencing (NGS) has dramatically improved the speed, accuracy, and efficiency of AST. These innovations are expected to contribute significantly to the market’s growth as they enable faster and more accurate results, allowing for more precise treatment plans.

Rising Incidence of Infectious Diseases: The increasing prevalence of infectious diseases worldwide, including viral, bacterial, and fungal infections, continues to drive the demand for effective AST solutions. Infections such as pneumonia, tuberculosis, and urinary tract infections (UTIs), coupled with the growing number of immunocompromised patients, have made AST a critical part of clinical diagnostics. The ability to promptly identify drug-resistant strains is critical to controlling the spread of these infections and preventing complications.

Government Initiatives and Investments: Governments across the globe have implemented various initiatives and allocated funds to combat antimicrobial resistance. For instance, the United States Centers for Disease Control and Prevention (CDC) and the European Centre for Disease Prevention and Control (ECDC) are actively supporting initiatives to promote better stewardship of antibiotics and the implementation of advanced diagnostic tools, which include antimicrobial susceptibility testing. Such investments and policies are expected to significantly drive the adoption of AST technologies.

Focus on Personalized Medicine: The growing trend toward personalized or precision medicine is further fueling the demand for AST. Personalized medicine focuses on tailoring medical treatment to the individual characteristics of each patient, such as their genetic makeup, environment, and lifestyle. AST plays a key role in this approach by ensuring that the right antimicrobial treatment is administered based on the patient's specific needs and the susceptibility profile of the infecting organism.

Key Segments:

By Product

Manual Tests

MIC Strip

Susceptibility Testing Disks

Susceptibility Plates

Automated Instruments

Consumables & Media

By Application

Drug Development

Susceptibility Testing

Others

By Technique

Automated AST

Etest Method

Dilution

Disk Diffusion

Others

By End-use

Hospitals

Diagnostic Laboratories

Biotechnology & Pharmaceutical Companies

Others

Key Players

Key Service Providers/Manufacturers

bioMérieux SA: [VITEK 2, VITEK MS]

Becton, Dickinson and Company: [BD Phoenix, BD BBL Sensi-Disc]

Thermo Fisher Scientific Inc.: [Sensititre AST System, Oxoid Antimicrobial Susceptibility Testing Discs]

Danaher Corporation: [MicroScan WalkAway System, DxM MicroScan WalkAway System]

Bio-Rad Laboratories, Inc.: [Microbial Identification System, RAPIDEC Carba NP]

Bruker Corporation: [MALDI Biotyper, MALDI Sepsityper]

Roche Diagnostics: [cobas BACT/ALERT, cobas 4800 System]

Accelerate Diagnostics, Inc.: [PhenoTest BC Kit, Pheno System]

HiMedia Laboratories: [HiDisc AST Discs, HiCrome Agar Media]

Liofilchem s.r.l.: [MIC Test Strips, Chromatic Media]

Make Enquiry about Antimicrobial Susceptibility Testing Market 

Conclusion:

The Antimicrobial Susceptibility Testing market is on a steady growth trajectory, with increasing demand for accurate and efficient diagnostic tools to tackle the global antimicrobial resistance crisis. The market's expansion will be largely driven by technological advancements, rising government initiatives, and the need to manage the growing prevalence of drug-resistant infections. As the healthcare industry continues to prioritize antimicrobial stewardship, the AST market is poised to play a pivotal role in shaping the future of clinical diagnostics and treatment strategies.

About the Report

The data presented in this release is based on comprehensive market research and analysis covering industry trends, key drivers, regional outlooks, and competitive dynamics. The report provides insights for investors, healthcare providers, technology vendors, and policymakers aiming to understand and capitalize on the growing operating room management sector.

Contact Us:

Jagney Dave - Vice President Of Client Engagement

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

[freyrsolutions]

Learn the EPA registration process for disinfectants antimicrobial products. Understand FIFRA rules, toxicity testing, labeling, state-level compliance.

[healthcaremarketanalysis]

Exploring the Antimicrobial Susceptibility Testing Market: Trends, Innovations, and Future Opportunities

The Antimicrobial Susceptibility Testing (AST) market has become a cornerstone in modern healthcare, playing a pivotal role in combating the growing threat of antimicrobial resistance (AMR). With the rise of multidrug-resistant pathogens, the need for accurate, efficient, and rapid AST solutions is more urgent than ever. This blog explores the key drivers, challenges, and advancements shaping the AST market, along with its future trajectory.

Download PDF Brochure

Overview of Antimicrobial Susceptibility Testing

Antimicrobial Susceptibility Testing evaluates the effectiveness of antibiotics, antifungals, and antivirals against specific pathogens. It determines the minimum inhibitory concentration (MIC) required to prevent microbial growth, guiding clinicians in selecting the most effective treatment options.

Key testing methods include:

Disk Diffusion Tests: A widely used method involving antibiotic-impregnated disks.

Broth Dilution Tests: Used to determine MIC values for various antimicrobial agents.

Automated AST Systems: Advanced platforms for rapid and high-throughput testing.

Molecular AST Methods: Techniques like PCR that identify resistance genes.

Market Drivers

Rising Antimicrobial Resistance

AMR is a global health crisis, with pathogens such as MRSA and multidrug-resistant E. coli becoming increasingly prevalent. This has escalated the demand for advanced AST solutions to manage infections effectively.

Growing Infectious Disease Burden

The increasing incidence of infectious diseases, including urinary tract infections (UTIs), bloodstream infections, and pneumonia, has spurred the adoption of AST in clinical laboratories and hospitals.

Technological Advancements

Innovations in AST, such as automated and rapid diagnostic systems, are enhancing accuracy and reducing turnaround times. Examples include MALDI-TOF-based systems and next-generation sequencing (NGS) for resistance profiling.

Regulatory and Government Initiatives

Governments worldwide are funding AMR surveillance programs, promoting AST adoption in healthcare settings. Initiatives like the Global Antimicrobial Resistance and Use Surveillance System (GLASS) underscore the importance of robust diagnostic solutions.

Challenges in the AST Market

High Costs of Advanced Systems

While automated AST systems improve efficiency, their high capital costs deter adoption in low-resource settings.

Lack of Standardization

Inconsistent testing standards across regions can affect the accuracy and comparability of results.

Emerging Resistance Mechanisms

The rapid evolution of resistance mechanisms outpaces the development of diagnostic tools, necessitating continuous innovation.

Skilled Workforce Shortages

Operating sophisticated AST technologies requires trained personnel, a challenge in underdeveloped regions.

Key Market Segments

The AST market is segmented based on products, testing methods, end users, and regions.

Products

Manual AST Products: Reagents, culture media, and susceptibility disks.

Automated AST Systems: High-throughput platforms like BD Phoenix and VITEK 2.

Testing Methods

Phenotypic methods, including broth dilution and disk diffusion.

Genotypic methods like molecular diagnostics and NGS.

End Users

Hospitals and diagnostic laboratories.

Pharmaceutical and biotechnology companies for drug discovery.

Academic and research institutes.

Regional Insights

North America leads the market due to advanced healthcare infrastructure and high awareness of AMR.

Europe follows closely, driven by stringent regulations and government funding.

Asia-Pacific is witnessing rapid growth owing to the rising infectious disease burden and increasing healthcare investments.

Technological Innovations in AST

Point-of-Care (POC) Testing

The development of portable AST devices enables rapid diagnosis in outpatient settings, improving treatment outcomes.

AI-Powered Diagnostics

Artificial Intelligence is being integrated into AST platforms to analyze complex datasets and predict resistance patterns.

Microfluidics-Based Systems

These systems enhance precision and speed while minimizing sample volume, making AST more accessible.

Whole Genome Sequencing (WGS)

WGS provides comprehensive insights into resistance mechanisms, guiding precision medicine approaches.

Competitive Landscape

The AST market is highly competitive, with key players driving innovation and expansion. Leading companies include:

Thermo Fisher Scientific

bioMérieux SA

BD (Becton, Dickinson and Company)

Danaher Corporation

HiMedia Laboratories

These companies focus on launching cutting-edge products, forming strategic collaborations, and expanding their global footprint.

Future Outlook

The AST market is poised for significant growth in the coming years. Factors such as the integration of advanced technologies, rising awareness about AMR, and increased funding for diagnostics will shape its trajectory. Additionally, the push for personalized medicine and targeted therapies will further drive the adoption of sophisticated AST tools.

Key trends to watch include:

Increased adoption of molecular diagnostics.

Development of AI-driven predictive models.

Expansion of POC testing capabilities in emerging markets.

Enhanced global AMR surveillance and data-sharing initiatives.

Conclusion

The Antimicrobial Susceptibility Testing market is a critical component of the global effort to combat antimicrobial resistance. As technology evolves and awareness grows, AST solutions will become more accessible, efficient, and impactful in guiding clinical decisions. By addressing challenges like cost and standardization, the market holds immense potential to revolutionize infectious disease management and safeguard public health.

[innovotechsblog]

Trusted Antibacterial Testing in Vancouver with Innovative Solutions for Diverse Industries | Innovotech

Innovotech, a renowned leader in antibacterial testing, brings over four decades of microbiology expertise and a stellar track record in providing comprehensive antimicrobial contract research and testing services. Trusted globally, their biofilm solutions have made significant impacts in various industries, spanning medical devices to agriculture. For clients seeking top-tier antibacterial testing in Vancouver and beyond, Innovotech's commitment to quality and innovation makes them an invaluable partner in addressing antibacterial-related challenges and advancing research endeavors. 

[soumyafwr]

Antimicrobial Susceptibility Testing Market Analysis, Size, Share, and Forecast 2031

[mitalipingale]

https://carbonfacesocial.org/blogs/49990/Antimicrobial-Susceptibility-Testing-Market-Analysis-Share-Size-and-Forecast-2031

The Antimicrobial Susceptibility Testing Market in 2023 is US$ 3.6 billion, and is expected to reach US$ 5.62 billion by 2031 at a CAGR of 5.70%.

[harmeet-saggi]

Antibiotic Resistance And The Future Of Infectious Disease Treatment

Are we on the verge of a post-antibiotic era? Can our current arsenal of antibiotics withstand the ever-evolving onslaught of antibiotic-resistant bacteria? These questions loom large as we grapple with the growing problem of antibiotic resistance. In this 1500-word blog, we will delve into the world of antibiotic resistance, exploring its causes, consequences, and innovative approaches to combat this looming health crisis. We'll also discover the best probiotics to take with antibiotics, explore natural penicillin alternatives, and learn about emerging solutions like phage therapy and antimicrobial supplements. Join us on this journey to understand the future of infectious disease treatment.

[healthcaremarketanalysis]

Antimicrobial Susceptibility Testing Market worth $4.7 billion | MarketsandMarkets

Antimicrobial Susceptibility Testing (AST) is a laboratory test used to determine the susceptibility of bacteria to various antibiotics. It is an important part of determining the best antibiotic to treat an infection. By performing Antimicrobial Susceptibility Testing, clinicians can identify which antibiotics will be effective in treating a particular infection, allowing them to choose the most appropriate treatment. The results of the Antimicrobial Susceptibility Testing can be used to determine the most effective therapy for the patient.

Antimicrobial Susceptibility Testing Market in terms of revenue was estimated to be worth $3.6 billion in 2022 and is poised to reach $4.7 billion by 2027, growing at a CAGR of 5.5% from 2022 to 2027 according to a new report by MarketsandMarkets™. The rising prevalence of infectious diseases, high antibiotic resistance, and supportive government measures to lessen the burden of infectious diseases can all be linked to the expansion of the antimicrobial susceptibility testing (AST) industry. The use of antimicrobial susceptibility testing is growing due to an increase in specific illnesses such pneumonia and bloodstream infections caused by E. coli, K. pneumoniae, P. aeruginosa, and others.

Download an Illustrative overview:

Browse in-depth TOC on "Antimicrobial Susceptibility Testing Market"

161 - Tables

40 - Figures

243 – Pages

Automated Laboratory Instruments segment to register a significant growth rate over the forecast period of 2022-2027

Based on the product type, the antimicrobial susceptibility testing market is segmented into Manual antimicrobial susceptibility testing products, Automated Laboratory Instruments, Culture and Growth Media, and Consumables. with each segment covering various products used in susceptibility testing. Automated Laboratory Instruments hold the largest share of the antimicrobial susceptibility testing market in 2022. The large share of this segment can be attributed to Getting fast results than the traditional procedures used in susceptibility testing

The hospitals and Diagnostic centers segment accounted for the largest share of the Antimicrobial Susceptibility Testing market, by the end-user market in 2022.

Based on End users, the antimicrobial susceptibility testing market is segmented into Hospitals and Diagnostic centers, Pharmaceutical and Biotechnology companies, Research & Academic Institutes, and Clinical research organizations.

North America to register major growth in the market during the forecast period

North America microcatheter market is anticipated to register the highest growth over the forecast period of 2022 to 2027. North America accounted for the largest share of 35.4% of the antimicrobial susceptibility testing market in 2022. This market is projected to reach USD 1.6 billion by 2027 from USD 1.2 billion in 2022, at a CAGR of 5.3% during the forecast period. The large share of North America can be attributed due to the growth in antibiotic resistance prevalence, the existence of important actors, an increase in healthcare spending, technological developments, and an increase in government activities in the area. Nonetheless, due to a rise in the region's population generally and rising investments in the healthcare industry, Asia-Pacific is expected to experience significant development.

Request for FREE Sample Pages:

Antimicrobial Susceptibility Testing Market Dynamics:

Drivers:

Rising incidence of infectious diseases coupled with epidemic and pandemic events

Increasing funding, research grants, and public-private investments

Technological advancements

Growing government initiatives to detect and control antimicrobial-resistant species

Emergence of multidrug resistance due to drug abuse

Restraints:

High cost of automated ID/AST systems

Opportunities:

Growth opportunities in emerging markets

Challenges:

Complex regulatory frameworks

Key Market Players:

As of 2022, prominent players are Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Bruker, Danaher Corporation.

Recent Developments

In Jan,2023 bioMerieux launched a automated instrument named MAESTRIA

In Aug,2022 BD India launched the BD MAX MDR-TB panel.

In May ,2022 Thermofisher scientific introduced automated antimicrobial susceptibility products.

Get 10% Free Customization on this Report:

Antimicrobial Susceptibility Testing Market Advantages:

Antimicrobial susceptibility testing (AST) is a laboratory technique used to determine the susceptibility or resistance of microorganisms to antimicrobial drugs. The market for AST is rapidly growing due to the increasing prevalence of infectious diseases and the need for appropriate antibiotic therapy. Here are some advantages of the antimicrobial susceptibility testing market:

Accurate Diagnosis: Antimicrobial susceptibility testing provides accurate and reliable results for the diagnosis of bacterial infections. This helps healthcare providers to select the appropriate antibiotics to treat the infection and prevent the development of antibiotic resistance.

Improved Patient Outcomes: By providing accurate information on the susceptibility or resistance of microorganisms to antimicrobial drugs, AST helps healthcare providers to make informed decisions regarding the treatment of bacterial infections. This can lead to improved patient outcomes and reduced healthcare costs.

Effective Management of Antibiotic Resistance: The misuse and overuse of antibiotics have led to the emergence of antibiotic-resistant bacteria, which is a major public health concern. AST helps to manage antibiotic resistance by providing information on the susceptibility or resistance of microorganisms to specific antibiotics.

Customized Treatment Plans: Antimicrobial susceptibility testing enables healthcare providers to customize treatment plans for individual patients based on their specific infection and the susceptibility or resistance of the microorganism causing the infection.

Growing Market: The antimicrobial susceptibility testing market is rapidly growing due to the increasing prevalence of infectious diseases and the need for appropriate antibiotic therapy. This presents significant opportunities for companies involved in the development and manufacture of AST products.

In summary, the antimicrobial susceptibility testing market is crucial for accurate diagnosis, effective management of antibiotic resistance, and customized treatment plans. It also presents significant opportunities for companies involved in the development and manufacture of AST products.

Antimicrobial Susceptibility Testing Market - Report Highlights:

The study consists of the average selling price (ASP) analysis for different products in the Antimicrobial susceptibiity testing products

The research study comprises the patent analysis of technologies/solutions used in the Antimicrobial susceptibility testing products

The new market study consists of the trends/disruptions impacting customers' businesses.

The new market study consists of information on key conferences and events in 2020–2027.

The new market study consists of the region-wise regulatory landscape.

The new market study consists of Porter's Five Forces Analysis

The new market study provides details of the strategies of the top 5 players operating in the market.

The competitive landscape chapter has been updated with the market evaluation matrix. The competitive landscape also includes the market share analysis of major global players (as of 2021), updated competitive leadership mapping, and competitive situations and trends.

The new market study comprises 25 players. These companies have emerged as key market players in recent years due to their products and various strategic investments undertaken in the medical aesthetic market space.

Updated financial information/product portfolio of players: The new edition of the report provides updated financial information in the context of the medical aesthetic market from January 2020 to July 2022 (depending on availability) for each listed company in graphical representation.

Updated market developments of profiled players: The current report includes the market developments from January 2020 to July 2022.

During the production cycle of the report, in-depth interviews were conducted with various primary respondents, which include key opinion leaders, subject matter experts, directors, and C-level executives of selected particle counters vendors to obtain and verify critical qualitative and quantitative information. This primary data was collected mainly through questionnaires, mails, and telephonic interviews.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1-888-600-6441

UK +44-800-368-9399

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

[innovotechsblog]

Expert Antibacterial Solutions for Research and Testing in Vancouver | Innovotech

Innovotech stands as an esteemed authority in the realm of antibacterial solutions in Vancouver. Leveraging over 40 years of collective expertise and an accredited quality system, they excel in offering comprehensive antimicrobial contract research and testing services. Innovotech's globally trusted biofilm products and testing methodologies are the preferred choice of researchers worldwide, ensuring reliable and effective antibacterial solutions. Their steadfast commitment to quality assurance guarantees precise and valuable results, solidifying Innovotech's position as a prominent figure in the field of antibacterial research and solutions in Vancouver.

[soumyafwr]

Antimicrobial Susceptibility Testing Market Analysis, Size, Share, and Forecast 2031